AGL logo

Agilon Health, Inc. (AGL)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

AGL steht fuer Agilon Health, Inc., ein Healthcare-Unternehmen mit einem Kurs von $0.43 (Marktkapitalisierung 178M). Bewertet mit 46/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 8. Feb. 2026
46/100 KI-Bewertung MCap 178M Vol 3M

Agilon Health, Inc. (AGL) Gesundheitswesen & Pipeline-Uebersicht

CEORonald Allan Williams
Mitarbeiter1076
HauptsitzAustin, TX, US
IPO-Jahr2021

Agilon Health is transforming senior healthcare by empowering primary care physicians with a value-based model, serving approximately 238,000 members. Despite current negative profitability, its focus on Medicare Advantage positions it for long-term growth in a rapidly expanding market.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 8. Feb. 2026

Investmentthese

Agilon Health presents a notable research candidate due to its strategic positioning in the growing Medicare Advantage market. The company's value-based care model, focusing on preventative care and chronic disease management, has the potential to drive significant cost savings and improve patient outcomes. While the company currently has a negative profit margin of -5.2% and a P/E ratio of -0.87, the long-term growth prospects are substantial. Key catalysts include expanding its network of physician partners and increasing its penetration in existing markets. Successful execution of its growth strategy could lead to significant revenue growth and improved profitability, making AGL an attractive investment for long-term investors. Monitor membership growth and improvements in gross margin to assess the company's progress.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Served approximately 238,000 senior members as of December 31, 2021, demonstrating significant market reach.
  • Includes 186,300 Medicare Advantage members, indicating a strong presence in a key growth market.
  • 51,700 Medicare fee-for-service beneficiaries, providing a diversified revenue stream.
  • Headquartered in Austin, Texas, a growing hub for healthcare innovation.
  • Beta of 0.07 indicates low volatility relative to the market.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Established network of physician partners.
  • Proprietary technology and data analytics platform.
  • Focus on value-based care.
  • Strong relationships with Medicare Advantage plans.

Schwaechen

  • Negative profit margin.
  • High operating expenses.
  • Dependence on Medicare Advantage and fee-for-service reimbursement models.
  • Limited geographic reach.

Katalysatoren

  • Ongoing: Expansion into new geographic markets, increasing membership base.
  • Ongoing: Continued growth in the Medicare Advantage market.
  • Upcoming: Potential partnerships with other healthcare providers.
  • Upcoming: Development of new technology and data analytics capabilities.
  • Ongoing: Improvements in patient engagement and satisfaction.

Risiken

  • Potential: Changes in healthcare regulations could negatively impact reimbursement rates.
  • Ongoing: Increased competition from other healthcare providers could erode market share.
  • Potential: Economic downturn could affect healthcare spending and member enrollment.
  • Ongoing: Dependence on Medicare Advantage and fee-for-service models exposes the company to reimbursement risks.
  • Potential: Failure to effectively manage patient care and control costs could impact profitability.

Wachstumschancen

  • Expanding into New Geographic Markets: Agilon has the opportunity to expand its network of physician partners and enter new geographic markets across the United States. The market for senior healthcare services is vast and underserved in many areas, presenting a significant growth opportunity. Successful expansion into new markets could significantly increase Agilon's membership base and revenue. This expansion could target states with favorable demographics and regulatory environments, potentially adding tens of thousands of new members within the next 3-5 years.
  • Increasing Medicare Advantage Penetration: Medicare Advantage is a rapidly growing segment of the healthcare market, and Agilon is well-positioned to capitalize on this trend. By increasing its penetration in existing markets and attracting more Medicare Advantage members, Agilon can drive significant revenue growth. Focus on marketing and outreach to educate seniors about the benefits of Medicare Advantage and Agilon's value-based care model. This could translate to a 15-20% increase in Medicare Advantage membership over the next two years.
  • Enhancing Technology and Data Analytics: Investing in technology and data analytics capabilities can further improve Agilon's ability to manage patient care effectively and reduce costs. By leveraging data to identify high-risk patients and personalize care plans, Agilon can improve health outcomes and drive cost savings. Development of proprietary algorithms and predictive models can provide a competitive advantage, potentially reducing costs by 5-10% per member annually.
  • Strategic Partnerships and Acquisitions: Agilon can pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. Partnering with other healthcare providers and organizations can create synergies and enhance Agilon's value proposition. Targeted acquisitions of smaller healthcare companies can provide access to new markets and technologies. These partnerships could add new service lines and expand the company's reach by 10-15% within the next three years.
  • Improving Patient Engagement and Satisfaction: Focusing on improving patient engagement and satisfaction can lead to better health outcomes and increased member retention. Implementing programs to encourage preventative care, provide personalized support, and address social determinants of health can improve patient satisfaction and reduce healthcare costs. Increased patient engagement can lead to a 5-7% reduction in hospital readmission rates and improve overall health outcomes.

Chancen

  • Expanding into new geographic markets.
  • Increasing Medicare Advantage penetration.
  • Enhancing technology and data analytics capabilities.
  • Strategic partnerships and acquisitions.

Risiken

  • Changes in healthcare regulations.
  • Increased competition from other healthcare providers.
  • Fluctuations in Medicare Advantage reimbursement rates.
  • Economic downturn affecting healthcare spending.

Wettbewerbsvorteile

  • Established network of physician partners provides a competitive advantage.
  • Proprietary technology and data analytics platform enhances care management capabilities.
  • Focus on value-based care aligns incentives and drives cost savings.
  • Strong relationships with Medicare Advantage plans provide access to a large market.

Ueber AGL

Agilon Health, Inc., founded in 2016 and headquartered in Austin, Texas, operates as a healthcare service provider focused on transforming healthcare for seniors. The company partners with primary care physicians (PCPs) in various communities across the United States, enabling them to deliver value-based care. Agilon's model involves taking on the financial risk for senior patients, aligning incentives to improve health outcomes and reduce costs. As of December 31, 2021, Agilon Health served approximately 238,000 senior members, including 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. This network of PCPs utilizes Agilon's technology and data analytics platform to manage patient care effectively, focusing on preventative care and chronic disease management. The company's evolution reflects a shift towards value-based care models in the healthcare industry, emphasizing quality and efficiency over traditional fee-for-service arrangements. Agilon Health aims to improve the healthcare experience for seniors while driving sustainable financial performance for its physician partners and shareholders.

Was das Unternehmen tut

  • Partners with primary care physicians to provide healthcare services for seniors.
  • Focuses on value-based care, aligning incentives to improve health outcomes and reduce costs.
  • Serves Medicare Advantage and Medicare fee-for-service beneficiaries.
  • Utilizes a technology and data analytics platform to manage patient care effectively.
  • Emphasizes preventative care and chronic disease management.
  • Takes on financial risk for senior patients, promoting efficient healthcare delivery.
  • Works to improve the healthcare experience for seniors.

Geschaeftsmodell

  • Agilon Health generates revenue by managing the healthcare costs for senior patients.
  • The company receives capitated payments for Medicare Advantage members.
  • It also serves Medicare fee-for-service beneficiaries, generating revenue through traditional fee-for-service arrangements.
  • Agilon shares in the cost savings generated through its value-based care model.

Branchenkontext

Agilon Health operates within the rapidly evolving healthcare industry, specifically focusing on value-based care for seniors. The market is driven by the increasing aging population and the shift towards managed care models like Medicare Advantage. The competitive landscape includes other healthcare service providers and managed care organizations. Agilon differentiates itself through its partnership model with primary care physicians and its focus on data-driven care management. The industry is experiencing significant growth, with Medicare Advantage enrollment projected to continue increasing, creating opportunities for companies like Agilon to expand their market share.

Wichtige Kunden

  • Senior citizens enrolled in Medicare Advantage plans.
  • Senior citizens receiving Medicare fee-for-service benefits.
  • Primary care physicians who partner with Agilon to manage their senior patients.
KI-Zuversicht: 71% Aktualisiert: 8. Feb. 2026

Finanzdaten

Chart & Info

Agilon Health, Inc. (AGL) Aktienkurs: $0.43 (-0.01, -2.24%)

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer AGL.

Kursziele

Wall-Street-Kurszielanalyse fuer AGL.

MoonshotScore

46/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von AGL auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Neueste Agilon Health, Inc.-Analyse

Haeufige Fragen zu AGL

What are the key factors to evaluate for AGL?

Agilon Health, Inc. (AGL) currently holds an AI score of 46/100, indicating low score. Key strength: Established network of physician partners.. Primary risk to monitor: Potential: Changes in healthcare regulations could negatively impact reimbursement rates.. This is not financial advice.

How frequently does AGL data refresh on this page?

AGL prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AGL's recent stock price performance?

Recent price movement in Agilon Health, Inc. (AGL) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established network of physician partners.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider AGL overvalued or undervalued right now?

Determining whether Agilon Health, Inc. (AGL) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying AGL?

Before investing in Agilon Health, Inc. (AGL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding AGL to a portfolio?

Potential reasons to consider Agilon Health, Inc. (AGL) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Established network of physician partners.. Additionally: Proprietary technology and data analytics platform.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of AGL?

Yes, most major brokerages offer fractional shares of Agilon Health, Inc. (AGL) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track AGL's earnings and financial reports?

Agilon Health, Inc. (AGL) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for AGL earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data is based on information available as of December 31, 2021.
  • Future performance is subject to market conditions and company-specific factors.
Datenquellen

Popular Stocks